41 results on '"Akiho, Hiraku"'
Search Results
2. Effect of Ramosetron on Stool Consistency in Male Patients With Irritable Bowel Syndrome With Diarrhea
3. Influence of the requirement for abdominal pain in the diagnosis of irritable bowel syndrome with constipation (IBS-C) under the Rome IV criteria using data from a large Japanese population-based internet survey
4. Impact of symptoms by gender and age in Japanese subjects with irritable bowel syndrome with constipation (IBS-C): a large population-based internet survey
5. Effect of ramosetron in female patients with irritable bowel syndrome with diarrhea: a phase III long-term study
6. Risk-Based Monitoring Approach to Ensure the Quality of Clinical Study Data and Enable Effective Monitoring
7. Cover Image
8. High‐dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double‐blind, placebo‐controlled study with a long‐term open‐label extension study in Japan
9. A randomized controlled and long-term linaclotide study of irritable bowel syndrome with constipation patients in Japan
10. Dose‐finding study of linaclotide in Japanese patients with chronic constipation: A phase II randomized, double‐blind, and placebo‐controlled study
11. Additional file 1: Figure S1. of Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan
12. Additional file 2: Figure S2. of Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan
13. Linaclotide is Effective and Safe for Patients with Irritable Bowel Syndrome with Constipation in Japan: A Phase III Randomized, Double-Blind, and Placebo-Controlled and Long-Term Extension Study
14. Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea
15. Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea
16. Risk-Based Monitoring Approach to Ensure the Quality of Clinical Study Data and Enable Effective Monitoring
17. Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan
18. Mo1626 Determining an Optimal Dose of Linaclotide in Use in Japanese Patients With Irritable Bowel Syndrome With Constipation: A Phase II Randomized, Double-Blind, Placebo-Controlled Study
19. Ramosetron Reduces Symptoms of Irritable Bowel Syndrome With Diarrhea and Improves Quality of Life in Women
20. Mo1280 Effect of Ramosetron in Female Patients With Irritable Bowel Syndrome With Diarrhea: Phase III Long-Term Study
21. Mo1281 Optimal Dose of Ramosetron in Female Patients With Irritable Bowel Syndrome With Diarrhea: A Randomized, Placebo-Controlled Phase II Trial
22. 315 Effect of Ramosetron in Female Patients With Irritable Bowel Syndrome With Diarrhea: A Randomized, Placebo-Controlled Phase III Trial
23. Mo1548 - Linaclotide is Effective and Safe for Patients with Irritable Bowel Syndrome with Constipation in Japan: A Phase III Randomized, Double-Blind, and Placebo-Controlled and Long-Term Extension Study
24. Su1543 - Dose-Finding of Linaclotide for Patients with Chronic Constipation in Japan: A Phase II Randomized, Double-Blind, and Placebo-Controlled Study
25. Mo1627 Abdominal Bloating Is the Most Bothersome Symptom in Irritable Bowel Syndrome With Constipation (IBS-C): A Large Population-Based Internet Survey in Japan
26. A Long-Term Study of Acotiamide in Patients With Functional Dyspepsia : Results From an Open-Labeled Phase III Trial in Japan on Safety and Efficacy
27. Pharmacological and clinical profile of ramosetron hydrochloride (Irribow®), a novel therapeutic agent for irritable bowel syndrome with diarrhea
28. Neuroprotective effect of YM-39558 in focal cerebral ischemia in cats
29. Neuroprotective Effect of YM-39558, Orotic Acid Ethylester, in Gerbil Forebrain Ischemia
30. Post-ischaemic treatment with orotic acid prevents neuronal injury in gerbil brain ischaemia
31. Low stringency hybridization study of the dopamine D4 receptor revealed D4-like mRNA distribution of the orphan seven-transmembrane receptor, APJ, in human brain
32. Inactivation of a Novel Neuropeptide Y/Peptide YY Receptor Gene in Primate Species
33. Effects of non-peptide Y1 antagonist BIBP3226 on NPY-induced pressor response and food intake
34. The pharmacological profiles of a novel M1 muscarinic agonist, YM796
35. Effect of orotic acid on the metabolism of cerebral cortical astrocytes during hypoxia and reoxygenation: An NMR spectroscopy study.
36. Postischaemic treatment with orotic acid prevents neuronal injury in gerbil brain ischaemia
37. Cover Image.
38. High‐dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double‐blind, placebo‐controlled study with a long‐term open‐label extension study in Japan.
39. The reduction in the number of β2-adrenoceptors in v-src-transformed NIH-3T3 fibroblasts
40. The possible phosphorylation of Gs by pp60v-SIC which underlies reduced coupling of Gs in NIH-3T3 fibroblasts
41. [Pharmacological and clinical profile of ramosetron hydrochloride (Irribow), a novel therapeutic agent for irritable bowel syndrome with diarrhea].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.